1. Merck and Sanofi both buying smaller cancer oncology companies at big premiums — The latest from ASH2019 conference — Biopharma Dive’s drug launch of the year: Zolgensma — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Boehringer Ingelheim Vetmedica


Sort By:
Title
Replies Views
Last Message ↓
  1. anonymous
    Replies:
    2
    Views:
    5,367
  2. Anonymous Mgr
    Replies:
    17
    Views:
    7,850
  3. anonymous
    Replies:
    14
    Views:
    4,701
  4. anonymous
    Replies:
    5
    Views:
    3,624
  5. anonymous
    Replies:
    0
    Views:
    1,413
  6. anonymous
    Replies:
    6
    Views:
    2,566
  7. anonymous
    Replies:
    0
    Views:
    2,578
  8. anonymous
    Replies:
    0
    Views:
    2,009
  9. anonymous
    Replies:
    0
    Views:
    2,240
  10. anonymous
    Replies:
    17
    Views:
    6,967
  11. anonymous
    Replies:
    72
    Views:
    26,034
  12. anonymous
    Replies:
    35
    Views:
    11,174
  13. anonymous
    Replies:
    16
    Views:
    5,948
  14. anonymous
    Replies:
    0
    Views:
    2,434
  15. anonymous
    Replies:
    20
    Views:
    6,012
  16. anonymous
    Replies:
    5
    Views:
    3,720
  17. anonymous
    Replies:
    8
    Views:
    4,185
  18. anonymous
    Replies:
    0
    Views:
    3,166
  19. anonymous
    Replies:
    2
    Views:
    4,630
  20. Anonymous
    Replies:
    8
    Views:
    6,508

Thread Display Options

Loading...